News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Amol Akhade Shared Treatment Algorithm for HR +/Her2 -mBC from ASCO25
Amol Akhade/hiranandanihospital.org
Jun 7, 2025, 14:53

Amol Akhade Shared Treatment Algorithm for HR +/Her2 -mBC from ASCO25

Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:

“Treatment Algorithm for HR +/Her2 -mBC . from ASCO25.”

Amol Akhade

Read OncoDaily’s Special Articles from ASCO25: 

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Clifford Hudis

Amol Akhade ASCO ASCO 2025 ASCO25 Breast Cancer cancer HR+/HER2- MBC OncoDaily Oncology
Special Coverage
Blog Posts
Aug 18, 2025, 20:57
Niranjala Siriwardena: Why I’m Fighting for Australia’s First Workplace Cancer Survivorship Policy
Voices
Aug 18, 2025, 20:47
Wafaa M Rashed: Final Words to the Tenth Cohort of the Policy Advocacy in Genetics and Genomics Course
Blog Posts
Aug 18, 2025, 20:36
Gashaw Arega: The Beginning of Childhood Cancer Care in Ethiopia
Opinion
Aug 18, 2025, 20:22
Soumen Das: From LMIC to LRS - Rethinking Global Health
Health Policy
Aug 18, 2025, 20:12
Niranjala Siriwardena: Building Australia’s First Workplace Cancer Survivorship Policy
Voices
Aug 18, 2025, 20:02
Confronting Stigma at the Crossroads of Hepatitis and Cancer - European Cancer Organisation
Positive
Aug 18, 2025, 19:53
Erin and Chloe Raise £800 for Lung Cancer Research - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 19:28
Liz O’Riordan: Everything You Need to Know about Breast Cancer Recurrence
Blog Posts
Aug 18, 2025, 19:17
Matteo Bauckneht: Pitfalls in PSMA-Based RLT - A Case-Based Review at EANM25
Insight
Aug 18, 2025, 18:55
NCODA Brings the BREAKWATER Trial into Practice
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer